Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,676,303
+$6,566,033 QoQ
Shares Held
209,332
-1.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#350
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $425,890,657 across 14 Drug Manufacturers - General names. ABBV ranks #4 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
412,665 | $104,804,529 | |
| 2 | LLY |
ELI LILLY & Co
|
78,019 | $93,578,336 | |
| 3 | MRK |
Merck & Co., Inc.
|
563,132 | $72,362,462 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
209,332 | $52,676,303 | |
| 5 | AMGN |
Amgen Inc
|
87,050 | $31,522,545 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
439,307 | $25,312,868 | |
| 7 | PFE |
Pfizer Inc
|
879,706 | $21,183,319 | |
| 8 | AZN |
Astrazeneca PLC
|
72,990 | $13,840,363 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,676,303 | 209,332 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $46,110,270 | 212,011 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $49,271,354 | 215,639 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $50,466,457 | 217,960 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $41,376,553 | 222,910 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,479,341 | 202,746 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $36,671,237 | 206,366 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $41,364,752 | 209,463 | Shares | Defined | 2024-11-26 | |
| 2024-06-30 | $34,092,343 | 198,766 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $36,136,469 | 198,443 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,859,485 | 199,132 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $29,488,090 | 197,827 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $26,896,688 | 199,634 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $31,201,935 | 195,783 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $31,858,502 | 197,132 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,841,732 | 192,547 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,225,304 | 216,932 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $35,188,081 | 217,063 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $26,948,119 | 199,026 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $21,381,558 | 198,216 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,446,637 | 181,522 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $19,287,617 | 178,226 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,420,981 | 162,585 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $13,029,712 | 148,758 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,351,854 | 146,179 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,149,263 | 146,335 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||